DTC Proposed Rule Leaves Room For Creativity In Meeting Standards
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency says it will be flexible in assessing if risk information in consumer-focused ads are "clear, conspicuous and neutral," but proposed rule also seeks comment on whether such information should be presented simultaneously in audio and video format.
You may also be interested in...
Rx Drug TV Ads Must Present ‘Major Statement’ Simultaneously In Audio & Visual Segments
FDA’s final rule on the major statement in DTC ads includes additional standard for presenting a drug’s side effects and contraindications in a clear, conspicuous and neutral manner. Rule permits ‘creative elements’ during presentation, including upbeat music.
Bill Would Make US FDA Issue Final Rule On Risk Information In Broadcast DTC Ads
Proposed rule issued in March 2010 requires ‘major statement’ on a drug’s side effects in ‘a clear, conspicuous, and neutral manner’ for TV and radio ads. Bill would mandate a final rule within six months.
Opioids, Abortion, And Drug Advertising: How A Califf-Led FDA Might Address Hot Button Rx Topics
Robert Califf offers some interesting clues as to how he’d handle top drug policy issues in his Senate confirmation hearing.